Single-Therapy Androgen Suppression in Men with Advanced Prostate Cancer

2000396 citationsJournal Article

Authors

Jerome Seidenfeld · Blue Cross Blue Shield Association

David J. Samson · Blue Cross Blue Shield Association

Vic Hasselblad · Duke University

Naomi Aronson · Blue Cross Blue Shield Association

Peter C. Albertsen · University of Connecticut

Charles L. Bennett · Blue Cross Blue Shield Association

Timothy J Wilt ·

Abstract

Survival after therapy with an LHRH agonist was equivalent to that after orchiectomy. No evidence shows a difference in effectiveness among the LHRH agonists. Survival rates may be somewhat lower if a nonsteroidal antiandrogen is used as monotherapy.

Topics & Keywords

Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research Hormonal and reproductive studies

Publication Details

Published in: Annals of Internal Medicine

Volume 132, Issue 7, pp. 566-577

DOI: 10.7326/0003-4819-132-7-200004040-00009

Field-Weighted Citation Impact: 10.80

Command Palette

Single-Therapy Androgen Suppression in Men with Advanced Prostate Cancer

Authors

Abstract

Topics & Keywords

Publication Details